COPD: Inhaled corticosteroid (ICS) and long-acting beta2-agonist (LABA) combination and oxygen saturation (OS) in patients (pts) with different plasma surfactant protein D (SP-D) level Source: International Congress 2015 – COPD: notable points Year: 2015
The influence of antileukotriene therapy with montelukast (M) on thromboxane B2 /leukotriene E4 (TXB2 /LTE4 ) ratio in the urine of asthmatic subjects and other inflammatory markers Source: Eur Respir J 2003; 22: Suppl. 45, 102s Year: 2003
The influence of the COPD exacerbation treatment on the MMP-9 concentration in serum, induced sputum and BAL Source: Eur Respir J 2005; 26: Suppl. 49, 298s Year: 2005
Plasma surfactant protein D (SP-D) in patients (pts) with stable (S) COPD and during COPD acute exacerbation (AE) Source: Annual Congress 2013 –COPD biomarkers Year: 2013
Acute effects of tiotropium (T), salmeterol (S) and formoterol (F) on arterial blood gases (ABGs) in patients with stable COPD Source: Eur Respir J 2005; 26: Suppl. 49, 576s Year: 2005
Plasma surfactant protein-D (SPD) concentration and severity of airflow limitation in COPD patients (pts) Source: International Congress 2016 – Biomarkers and phenotypes of COPD Year: 2016
Levels of alkaline phosphatase (ALP), albumin (ALB) and D dimer (DD) in bronchoalveolar lavage (BAL) in patients with Interstitial lung disease (ILD) Source: Eur Respir J 2002; 20: Suppl. 38, 468s Year: 2002
Influence of tiotropium bromide (TB) and carbocysteine (C) on mucociliary clearance (MCC) in patients with COPD Source: Annual Congress 2012 - COPD treatment and varia Year: 2012
Effect of tiotropium on sputum and serum inflammatory markers and exacerbations in COPD Source: Eur Respir J 2007; 30: 472-478 Year: 2007
The 3-nitrothyrozine and total nitrate/nitrite (TNN) levels in exhaled breath condensate (EBC) in patients with bronchial asthma (BA) Source: Annual Congress 2009 - Airway inflammation and asthma control Year: 2009
Eicosanoid concentrations in induced sputum (IS) and exhaled breath condensate (EBC) in stable asthmatics with aspirin-tolerant (ATA) and aspirin-intolerant asthma (AIA) Source: Eur Respir J 2004; 24: Suppl. 48, 679s Year: 2004
Late-breaking abstract: Repeated analysis of alpha-1-antitrypsin concentrations in sputum, lavage and serum of smokers with and without COPD Source: Annual Congress 2011 - Cell biology of lung disease Year: 2011
Elevated TNF-α and interleukin-6 levels in breath condensate and serum of patients with non-CF bronchiectasis: comparison to COPD Source: Eur Respir J 2005; 26: Suppl. 49, 227s Year: 2005
Interleukin-2 in blood serum (BS), expired air condensate (EAC) and nazal lavage fluid (NLF) in children with bronchial asthma (BA) Source: Eur Respir J 2003; 22: Suppl. 45, 398s Year: 2003
Evaluation of prostaglandin-E-main urinary metabolite (PGE-MUM) in idiopathic pulmonary fibrosis (IPF) Source: Eur Respir J 2007; 30: Suppl. 51, 573s Year: 2007
Anti-inflammatory effect of montelukast (ML) and inhaled steroids (ICS) on clinical parameters and serum levels of NO in asthmatic children Source: Eur Respir J 2003; 22: Suppl. 45, 132s Year: 2003
Prospective nitrite, nitrate and cys-leukotriene (cys-LTs ) measurements in EBC (exhaled breath condensate) in asthmatic children and relation to outcome during inhaled steroid (IS) reduction Source: Eur Respir J 2003; 22: Suppl. 45, 534s Year: 2003
Relation between the acute response to salbutamol and long-term FEV1 responses to tiotropium (TIO), formoterol (FORM) and its combination (T+F) in COPD patients Source: Eur Respir J 2003; 22: Suppl. 45, 4s Year: 2003
QVA149 compared with salmeterol/fluticasone (SFC) on exacerbations and its correlation with baseline blood eosinophils: A pooled analysis of LANTERN and ILLUMINATE Source: International Congress 2015 – New data on established treatments for asthma and COPD Year: 2015
Serum surfactant protein D (SP-D) is a lung derived biomarker for COPD that is responsive to treatment with oral corticosteroids Source: Annual Congress 2008 - Biomarkers and disease assessment in COPD Year: 2008